What is the recommended diagnostic workup and management for an infant with PHACE syndrome (Posterior fossa anomalies, Hemangioma, Arterial anomalies, Cardiac anomalies, Eye anomalies) presenting with a large segmental facial hemangioma?

PHACE Syndrome: Diagnostic Workup and Management

Any infant with a large segmental facial hemangioma (>5 cm) or segmental hemangioma involving the face, scalp, or neck requires immediate comprehensive screening for PHACE syndrome, as approximately 30% of these infants will have this condition 1.

Diagnostic Workup Algorithm

Initial Recognition Criteria

• Large segmental facial hemangioma (typically >5 cm diameter) involving face, scalp, and/or neck 1
• Important caveat: Even smaller facial hemangiomas warrant evaluation, as cerebrovascular and other anomalies can occur regardless of hemangioma size 2
• Segmental hemangiomas in "beard distribution" (lower face/anterior neck) carry additional risk for airway involvement 1

Required Imaging Studies

Brain and Vascular Imaging:

• Brain MRI with MRA to evaluate for:
  • Cerebrovascular anomalies (present in >90% of PHACE cases) 1
  • Posterior fossa malformations (52% of cases) 1
  • These are the most common extracutaneous features and critical for stroke risk assessment 3

Cardiac Evaluation:

• Echocardiography and cardiac MRI/CT to assess for:
  • Coarctation of the aorta
  • Other cardiac defects (present in 67% of cases) 1
  • Aortic arch anomalies that may lead to critical stenosis 4

Ophthalmologic Assessment:

• Complete ophthalmologic examination for:
  • Ocular colobomas 5
  • Structural eye abnormalities
  • Assessment for amblyopia risk if periocular involvement 1

Additional Screening:

• Evaluate for ventral midline defects (sternal cleft, supraumbilical raphe) - hence "PHACES" 1
• Airway evaluation if hemangioma involves lower face/neck in beard distribution, as approximately 50% with airway hemangiomas have cutaneous lesions 1, 6

Management Approach

Multidisciplinary Team Required

Coordinate care involving:

• Dermatology
• Neurology (for cerebrovascular anomalies and stroke risk)
• Cardiology (for cardiac/aortic defects)
• Ophthalmology (for ocular complications)
• Otolaryngology (if airway involvement suspected)

Treatment Considerations

The presence of PHACE syndrome is an indication for treatment 1, falling under the category of "structural anomalies" that warrant intervention.

Beta-blocker therapy (propranolol) is the treatment of choice for the hemangioma component:

• Demonstrated efficacy in reducing hemangioma size 7
• Improvement typically seen within 1 month, with near-complete resolution by 6 months 7
• Represents superior efficacy and safety compared to older corticosteroid approaches 1

Critical Monitoring

Stroke Risk Management:

• Cerebrovascular anomalies create stroke risk requiring neurologic surveillance 4, 2
• Serial neurologic assessments throughout infancy and childhood
• Consider antiplatelet therapy in consultation with neurology for significant arterial anomalies

Cardiac Monitoring:

• Regular cardiology follow-up for aortic arch stenosis progression
• Monitor for development of critical coarctation 4

Ophthalmologic Surveillance:

• Serial eye examinations to prevent amblyopia if periocular involvement
• Risk factors include lesion >1 cm, upper eyelid involvement, ptosis, medial location 1

Common Pitfalls to Avoid

1. Don't wait for hemangioma to reach 5 cm: Smaller facial segmental hemangiomas can still be associated with significant cerebrovascular and other anomalies 2

2. Don't assume isolated cutaneous disease: The hemangioma is merely the visible marker of a multi-system syndrome with potentially life-threatening complications 4

3. Don't delay imaging: Early diagnosis is essential to prevent serious complications including stroke, seizures, visual impairment, and critical cardiac defects 5, 4

4. Don't overlook airway involvement: Beard distribution hemangiomas require airway evaluation, as subglottic hemangiomas can cause life-threatening obstruction 1, 6

5. Don't treat in isolation: PHACE syndrome requires coordinated multidisciplinary management, not just dermatologic treatment 5, 8